AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 169 filers reported holding AXSOME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $673,383 | +16.9% | 8,365 | +15.9% | 0.00% | 0.0% |
| Q1 2024 | $575,836 | +5.6% | 7,216 | +5.3% | 0.00% | 0.0% |
| Q4 2023 | $545,351 | +22.2% | 6,852 | +7.3% | 0.00% | 0.0% |
| Q3 2023 | $446,457 | -2.5% | 6,388 | +0.2% | 0.00% | 0.0% |
| Q2 2023 | $458,107 | +10.1% | 6,375 | -5.5% | 0.00% | 0.0% |
| Q1 2023 | $416,093 | -41.5% | 6,746 | -26.8% | 0.00% | 0.0% |
| Q4 2022 | $710,753 | +72.9% | 9,215 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $411,000 | -37.0% | 9,221 | -4.6% | 0.00% | 0.0% |
| Q2 2021 | $652,000 | +7.4% | 9,668 | -9.8% | 0.00% | 0.0% |
| Q1 2021 | $607,000 | -33.0% | 10,721 | -3.6% | 0.00% | -50.0% |
| Q4 2020 | $906,000 | +7.1% | 11,121 | -6.3% | 0.00% | 0.0% |
| Q3 2020 | $846,000 | -43.0% | 11,875 | -34.2% | 0.00% | -50.0% |
| Q2 2020 | $1,485,000 | +142.3% | 18,050 | +73.1% | 0.00% | +100.0% |
| Q1 2020 | $613,000 | -58.6% | 10,426 | -27.2% | 0.00% | -50.0% |
| Q4 2019 | $1,479,000 | – | 14,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |